XML 35 R28.htm IDEA: XBRL DOCUMENT v2.3.0.15
COMPUTATION OF EARNINGS (LOSS) PER SHARE (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended9 Months Ended12 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Dec. 31, 2010
Information related to EPS computation     
Net income (loss) allocated to common shareholders$ 1,572$ 8,438$ 24,953$ 23,733 
Basic:     
Weighted-average common shares outstanding (in shares)27,46627,01727,33526,972 
Basic (in dollars per share)$ 0.05$ 0.26$ 0.75$ 0.72 
Diluted:     
Weighted-average shares outstanding used in basic calculation (in shares)27,46627,01727,33526,972 
Dilutive effect of options (in shares)112235114260 
Dilutive effect of unvested restricted stock (in shares)2777130667 
Weighted-average common stock and common stock equivalents (in shares)27,85527,32327,75527,299 
Diluted (in dollars per share)$ 0.05$ 0.25$ 0.74$ 0.72 
Common Stock
     
Information related to EPS computation     
Net income (loss) allocated to common shareholders1,2986,94520,58119,529 
Common Stock | Continuing Operations
     
Information related to EPS computation     
Net income (loss) allocated to common shareholders1,2986,87519,00519,832 
Basic:     
Basic (in dollars per share)$ 0.05$ 0.25$ 0.70$ 0.74 
Diluted:     
Diluted (in dollars per share)$ 0.05$ 0.25$ 0.68$ 0.73 
Common Stock | Discontinued Operations
     
Information related to EPS computation     
Net income (loss) allocated to common shareholders 701,576(303) 
Basic:     
Basic (in dollars per share)$ 0.00$ 0.01$ 0.05$ (0.02) 
Diluted:     
Diluted (in dollars per share)$ 0.00$ 0.00$ 0.06$ (0.01) 
Series A Preferred Stock
     
Information related to EPS computation     
Series A 3% Redeemable Convertible Preferred Stock, dividend rate (as a percent)  3.00% 3.00%
Net income (loss) allocated to common shareholders1,1312,3136,9186,638 
Diluted:     
Stock issuable upon conversion of the Series A Preferred Stock (in shares)5,8065,8065,8065,806 
Stock awards excluded from calculation as their effect would be anti-dilutive (in shares)1,3252,1051,0262,067 
Series A Preferred Stock | Continuing Operations
     
Information related to EPS computation     
Net income (loss) allocated to common shareholders1,1312,2986,5836,703 
Series A Preferred Stock | Discontinued Operations
     
Information related to EPS computation     
Net income (loss) allocated to common shareholders $ 15$ 335$ (65)